News for DiaSorin S.p.A. (DSRLF)

DiaSorin S.p.A. (OTCPK:DSRLF) Q4 2024 Results Conference Call March 14, 2025 12:30 PM ETCompany ParticipantsCarlo Rosa - CEOPiergiorgio Pedron -...

The following slide deck was published by DiaSorin S.p.A.

Thyroid function testing industry is projected to witness a CAGR of 6.1% during the period 2024-2032. This growth can be attributed to advancements in...

Infectious Disease Diagnostics Market size was valued at USD 22.94 billion in 2023 to USD 43.09 billion by 2031...

The immunoassay market is set for robust growth, projected to expand from USD 35.12 billion in 2023 to USD 54.27 billion by 2031, at a CAGR of 5.59%. Key...

Influenza Diagnostics Market will reach a value of USD 1.46 Billion by 2031, with a CAGR of 3.5% during the forecast period (2024-2031)....

With rising chronic disease rates and increasing collaboration between pharmaceutical companies and academia, the nanomedicine market is poised for...

Rising incidence of chronic diseases, growing adoption of point-of-care testing and increase in geriatric population are the major factors which drive the...

The market is growing due to surging cases of Hepatitis E, especially in advancing regions where sanitation is deficient and pollution is common....

DiaSorin S.p.A. (OTCPK:DSRLF) Q2 2024 Earnings Conference Call July 29, 2024 11:00 AM ETCompany ParticipantsCarlo Rosa - Chief Executive OfficerPiergiorgio...

The following slide deck was published by DiaSorin S.p.A.

ST. LOUIS, July 18, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention,...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Cardiac Troponin Market...

The cardiac marker testing market is driven by the rising prevalence of cardiovascular diseases, increasing awareness of early diagnosis, and advancements...

Chicago, April 16, 2024 (GLOBE NEWSWIRE) -- In Vitro Diagnostics market in terms of revenue was estimated to be worth $85.2 billion in 2024 and is poised...

The norovirus diagnostics market was valued at USD 65.5 Billion in 2023 and is expected to reach USD 130.4 Billion by 2032 at a CAGR of 7.9%....

The global influenza diagnostics market size and share are currently valued at USD 0.79 billion in 2023. It is anticipated to generate an estimated revenue...

Intense competition among key players drives innovation and product differentiation in the helicobacter pylori non-invasive testing market....

Key blood transfusion diagnostics market players include Immucor, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Quotient Limited, Beckman Coulter,...